These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38829139)

  • 21. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
    Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
    Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
    J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
    Silva de Castro I; Gordon SN; Liu J; Bissa M; McKinnon K; Trinh HV; Doster MN; Schifanella L; Liyanage NP; Cao J; Cheng O; Foulds K; Roederer M; Koup RA; Shen X; Tomaras GD; Venzon DJ; Forthal DN; Fouts T; Montefiori DC; Tartaglia J; Rao M; Ostrowski M; Franchini G; Vaccari M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
    Kannanganat S; Nigam P; Velu V; Earl PL; Lai L; Chennareddi L; Lawson B; Wilson RL; Montefiori DC; Kozlowski PA; Moss B; Robinson HL; Amara RR
    J Immunol; 2010 Dec; 185(12):7262-73. PubMed ID: 21076059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.
    Jensen K; Nabi R; Van Rompay KKA; Robichaux S; Lifson JD; Piatak M; Jacobs WR; Fennelly G; Canfield D; Mollan KR; Hudgens MG; Larsen MH; Amedee AM; Kozlowski PA; De Paris K
    J Virol; 2016 Aug; 90(16):7285-7302. PubMed ID: 27252535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys.
    Sun C; Chen Z; Tang X; Zhang Y; Feng L; Du Y; Xiao L; Liu L; Zhu W; Chen L; Zhang L
    J Virol; 2013 May; 87(10):5669-77. PubMed ID: 23487457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.
    Reynolds MR; Weiler AM; Piaskowski SM; Piatak M; Robertson HT; Allison DB; Bett AJ; Casimiro DR; Shiver JW; Wilson NA; Lifson JD; Koff WC; Watkins DI
    Vaccine; 2012 Jun; 30(30):4465-75. PubMed ID: 22569124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.
    von Gegerfelt A; Valentin A; Alicea C; Van Rompay KK; Marthas ML; Montefiori DC; Pavlakis GN; Felber BK
    J Immunol; 2010 Sep; 185(6):3348-58. PubMed ID: 20702730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
    Hel Z; Nacsa J; Tsai WP; Thornton A; Giuliani L; Tartaglia J; Franchini G
    Virology; 2002 Dec; 304(1):125-34. PubMed ID: 12490410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.
    Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Carville A; Aldovini A
    J Virol; 2013 Apr; 87(8):4738-50. PubMed ID: 23408627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
    Liu J; O'Brien KL; Lynch DM; Simmons NL; La Porte A; Riggs AM; Abbink P; Coffey RT; Grandpre LE; Seaman MS; Landucci G; Forthal DN; Montefiori DC; Carville A; Mansfield KG; Havenga MJ; Pau MG; Goudsmit J; Barouch DH
    Nature; 2009 Jan; 457(7225):87-91. PubMed ID: 18997770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
    Wilks AB; Christian EC; Seaman MS; Sircar P; Carville A; Gomez CE; Esteban M; Pantaleo G; Barouch DH; Letvin NL; Permar SR
    J Immunol; 2010 Dec; 185(11):7097-106. PubMed ID: 21041730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
    Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
    Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
    Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
    PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
    Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M
    J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
    Harwood OE; Balgeman AJ; Weaver AJ; Ellis-Connell AL; Weiler AM; Erickson KN; Matschke LM; Golfinos AE; Vezys V; Skinner PJ; Safrit JT; Edlefsen PT; Reynolds MR; Friedrich TC; O'Connor SL
    J Virol; 2022 Dec; 96(23):e0142422. PubMed ID: 36377872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.